[HTML][HTML] Immune profiling uncovers memory T-cell responses with a Th17 signature in cancer patients with previous SARS-CoV-2 infection followed by mRNA …
M Echaide, I Labiano, M Delgado… - Cancers, 2022 - mdpi.com
Simple Summary Cancer patients are considered a high-risk group for infectious diseases
including COVID-19. The protective effects of vaccination are unclear in oncologic patients …
including COVID-19. The protective effects of vaccination are unclear in oncologic patients …
Immune profiling uncovers memory T-cell responses with a Th17 signature in cancer patients with previous SARS-CoV-2 infection followed by mRNA vaccination.
M Echaide, I Labiano, M Delgado… - 2022 - cabidigitallibrary.org
It is unclear whether patients with cancer present inherently impaired responses to COVID-
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination.
M Echaide, I Labiano, M Delgado… - Cancers, 2022 - europepmc.org
It is unclear whether patients with cancer present inherently impaired responses to COVID-
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination
M Echaide, I Labiano, M Delgado… - …, 2022 - pubmed.ncbi.nlm.nih.gov
It is unclear whether patients with cancer present inherently impaired responses to COVID-
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination
M Echaide, I Labiano, M Delgado, AF de Lascoiti… - …, 2022 - search.proquest.com
It is unclear whether patients with cancer present inherently impaired responses to COVID-
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …
[PDF][PDF] Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA …
M Echaide, I Labiano, M Delgado… - 2022 - investigacion.unirioja.es
It is unclear whether patients with cancer present inherently impaired responses to COVID-
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …
[HTML][HTML] Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA …
M Echaide, I Labiano, M Delgado, AF de Lascoiti… - Cancers, 2022 - ncbi.nlm.nih.gov
It is unclear whether patients with cancer present inherently impaired responses to COVID-
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …
19 and vaccination due to their treatments, neoplastic diseases or both. To address this …